Attached files
| file | filename |
|---|---|
| 8-K/A - 8-K/A - AMAG PHARMACEUTICALS, INC. | a14-26737_18ka.htm |
| EX-99.2 - EX-99.2 - AMAG PHARMACEUTICALS, INC. | a14-26737_1ex99d2.htm |
| EX-99.3 - EX-99.3 - AMAG PHARMACEUTICALS, INC. | a14-26737_1ex99d3.htm |
| EX-23.1 - EX-23.1 - AMAG PHARMACEUTICALS, INC. | a14-26737_1ex23d1.htm |
| EX-99.1 - EX-99.1 - AMAG PHARMACEUTICALS, INC. | a14-26737_1ex99d1.htm |
Exhibit 23.2
Consent of Independent Auditor
AMAG Pharmaceuticals, Inc.
Waltham, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-192132) and Form S-8 (File Nos. 333-82292, 333-131656, 333-148682, 333-159938, 333-168786, 333-182821, 333-190435 and 333-197873) of AMAG Pharmaceuticals, Inc. of our report dated June 30, 2014, relating to the consolidated financial statements of Lumara Health Inc. (formerly K-V Pharmaceutical Company), which appears in this Form 8-K/A.
/s/ BDO USA, LLP
Chicago, Illinois
January 9, 2015